» Articles » PMID: 15315760

Mouse Development and Cell Proliferation in the Absence of D-cyclins

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2004 Aug 19
PMID 15315760
Citations 292
Authors
Affiliations
Soon will be listed here.
Abstract

D-type cyclins (cyclins D1, D2, and D3) are regarded as essential links between cell environment and the core cell cycle machinery. We tested the requirement for D-cyclins in mouse development and in proliferation by generating mice lacking all D-cyclins. We found that these cyclin D1(-/-)D2(-/-)D3(-/-) mice develop until mid/late gestation and die due to heart abnormalities combined with a severe anemia. Our analyses revealed that the D-cyclins are critically required for the expansion of hematopoietic stem cells. In contrast, cyclin D-deficient fibroblasts proliferate nearly normally but show increased requirement for mitogenic stimulation in cell cycle re-entry. We found that the proliferation of cyclin D1(-/-)D2(-/-)D3(-/-) cells is resistant to the inhibition by p16(INK4a), but it critically depends on CDK2. Lastly, we found that cells lacking D-cyclins display reduced susceptibility to the oncogenic transformation. Our results reveal the presence of alternative mechanisms that allow cell cycle progression in a cyclin D-independent fashion.

Citing Articles

Impact of G1 phase kinetics on the acquisition of stemness in cancer cells: the critical role of cyclin D.

Ahmadi Y, Faiq T, Abolhasani S Mol Biol Rep. 2025; 52(1):230.

PMID: 39951181 DOI: 10.1007/s11033-025-10351-3.


SpaCcLink: exploring downstream signaling regulations with graph attention network for systematic inference of spatial cell-cell communication.

Liu J, Ma L, Ju F, Zhao C, Yu L BMC Biol. 2025; 23(1):44.

PMID: 39939849 PMC: 11823213. DOI: 10.1186/s12915-025-02141-x.


Targeting CDK4/6 in breast cancer.

Shanabag A, Armand J, Son E, Yang H Exp Mol Med. 2025; 57(2):312-322.

PMID: 39930131 PMC: 11873051. DOI: 10.1038/s12276-025-01395-3.


The G-S transition is promoted by Rb degradation via the E3 ligase UBR5.

Zhang S, Valenzuela L, Zatulovskiy E, Mangiante L, Curtis C, Skotheim J Sci Adv. 2024; 10(43):eadq6858.

PMID: 39441926 PMC: 11498223. DOI: 10.1126/sciadv.adq6858.


Identification of CDK4/6 Inhibitors as Small Molecule NLRP3 Inflammasome Activators that Facilitate IL-1β Secretion and T Cell Adjuvanticity.

Weiss A, Lopez 2nd M, Rosenberger M, Kim J, Shen J, Chen Q J Med Chem. 2024; 67(17):14974-14985.

PMID: 39162654 PMC: 11736968. DOI: 10.1021/acs.jmedchem.4c00516.